Infections, Respiratory
15
2
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (15)
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Novel Technologies for Respiratory Virus Identification
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults
Profiling Recovery of Those Discharged Into the Community With COVID-19
Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department
Evaluation of the National Tool for Observation of Infection Prevention Measures in the Healthcare (NOST)
Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers
Comparison Between Different Ventilator Hyperinflation Maneuvers
NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health
Yogurt Study in Children 2-4 Years Old Attending Daycare